Cancer
Showing NaN - NaN of 104
Cancer Trial in Nashville
Recruiting
- Cancer
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Mar 1, 2022
Cancer Trial in United States (mAb RAV12)
Completed
- Cancer
- monoclonal antibody RAV12
-
Santa Monica, California
- +4 more
Feb 4, 2022
HER2-positive, Adenocarcinoma, Bile Duct Cancer Trial in United States (CT-0508)
Recruiting
- HER2-positive
- +30 more
- CT-0508
-
Duarte, California
- +4 more
Feb 1, 2022
Head and Neck Squamous Cell Carcinoma, Cancer, Cancer of Head and Neck Trial in United States (Pembrolizumab, Radiation therapy,
Recruiting
- Head and Neck Squamous Cell Carcinoma
- +14 more
- Pembrolizumab
- +2 more
-
Tucson, Arizona
- +6 more
Oct 7, 2021
Neuroinflammation in Chronic Systemic Symptoms (CSS)
Recruiting
- Cancer
- +5 more
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 8, 2021
Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in Australia, United States (AMG 232, Trametinib, Dabrafenib)
Completed
- Advanced Malignancy
- +6 more
- AMG 232
- +2 more
-
Los Angeles, California
- +6 more
Mar 24, 2021
Renal Cell Carcinoma (RCC), Cancer Trial in Worldwide (pazopanib, )
Completed
- Renal Cell Carcinoma (RCC)
- Cancer
- pazopanib
- placebo
-
Jonesboro, Arkansas
- +311 more
Oct 29, 2020
PRelationship Between Physical Activity and Cancer Ris
Completed
- Cancer
-
Nashville, Tennessee
- +1 more
Sep 8, 2020
Tumors, Cancer Trial in United States
Active, not recruiting
- Neoplasms
- Cancer
-
Phoenix, Arizona
- +34 more
Jul 29, 2020
Synovial Sarcoma, Cancer, Soft Tissue Sarcoma Trial in Canada, United States (LV305, G305, LV305-matching )
Terminated
- Synovial Sarcoma
- +4 more
- LV305
- +3 more
-
Scottsdale, Arizona
- +28 more
Apr 3, 2020
Caris Biorepository Research Protocol
Recruiting
- Cancer
-
Albany, Georgia
- +6 more
Jan 21, 2020